We are monitoring the impact of COVID-19 on APAC Peptide Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2021
ID: 12050
Share on
Share on

Asia-Pacific Peptide Therapeutics Market Research Report – Segmented By Type, Application, Type of Manufacturers, Route of Administration, Synthesis Technology & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2021 to 2026)

Pulished: August, 2021
ID: 12050
Pages: 100

APAC Peptide Therapeutics Market Size (2021 to 2026)

The size of the Asia-pacific peptide therapeutics market is estimated to be growing at a CAGR of 9.96% from 2021 to 2026.

The increase in the prevalence of different types of cancer and metabolic disorders, favorable investments in research and development of newer drugs, and technological advancements in peptide therapeutics are the major growth factors of the market. According to the World Health Organization (WHO), chronic diseases such as cancer, cardiovascular disease, and diabetes are the leading causes of death and disability worldwide. Furthermore, chronic disease rates are accelerating globally, increasing in all regions and dominating all socioeconomic classes. In 2020, the contribution of chronic disease was estimated to have caused 75% of all deaths and 62 % of the global disease burden. Hence, the increasing incidence of chronic diseases is accelerating the need for effective therapies, which is expected to drive the growth of the APAC peptide therapeutics market.

The increase in metabolic and infectious disorders cases is expected to drive market growth during the forecast period. The Centers for Disease Control and Prevention (CDC) reports that approximately 35.2 million people in Asia were diagnosed with diabetes in 2020. In addition, the prevalence of diabetes continues to increase from previous decades. Furthermore, diseases such as brain disorders and cancer are increasingly common, leading to rising health care costs.

Patients and healthcare professionals are increasingly aware of the negative effects of chemotherapy and radiation therapy, leading to a greater emphasis on alternative therapies such as peptide drugs. The growing demand for effective and rapid-acting therapies is expected to further fuel growth.

However, the instability of peptide therapeutics and the high cost for drug development, stringent regulatory requirements for drug approval, expiration of drugs, and exclusivity of successful peptide therapies during the forecast period will have a restrictive impact on the market.

Impact of COVID-19 on the APAC peptide therapeutics market:

COVID-19 could positively impact the therapeutic peptide market, as peptide drugs are seen as a treatment option to treat COVID-19. However, the peptide therapeutics that had applications involving oncology, metabolic disorders, etc., have been disrupted due to drug shortages and supply chain issues, and slow progress in clinical trials related to non-COVID-19 therapies.

Government funding for the use of peptides in the production of COVID-19 vaccines is expected to provide a potential incentive for the adoption of the peptides, potentially driving the growth of the APAC peptide therapeutics market.

This research report on the North American peptide therapeutics market has been segmented and sub-segmented into the following categories:

By Type:

  • Generic
  • Innovative

By Application:

  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Anti-infection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others

By Type of Manufacturers:

  • In-house
  • Outsourced

By Route of Administration:

  • Parenteral Route
  • Oral Route
  • Pulmonary
  • Mucosal
  • Others

By Synthesis Technology:

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The APAC peptide therapeutics market is expected to expand significantly over the forecast period, owing to the rising number of biotech companies and government healthcare expenditure, as well as the growing prevalence of cancer and nervous system disorders; these factors will have a positive impact on the market growth in APAC region.

Countries with financial difficulties such as Pakistan, India, the Philippines, and Vietnam are more likely to implement cost-effective and reliable peptide therapies to lower healthcare costs. The Cancer Society study suggests that 1.75 million new cancer cases and 606,620 deaths will be diagnosed by 2020. Governments in the APAC region are likely to receive favorable discounts for peptide therapies, public awareness, and the implementation of policies to encourage consumers and clinicians to seek cost-effective peptide therapy to introduce investigational drugs for the treatment of serious disorders.

According to the Australian Bureau of Statistics, from their self-acclaimed reports, an estimated nearly 1.5 million Australians and 4.99% of the total population got diabetes in 2019. Therefore, increased investments in developing new drugs for peptide therapies and the applicability of therapies for the treatment of viral infections and chronic diseases are expected to accelerate the APAC peptide therapy market revenue during the forecast period.

KEY MARKET PLAYERS:

Eli Lilly and Company, Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, AstraZeneca PLC, GlaxoSmithKline plc, Novo Nordisk A/S., Novartis AG, Zealand Pharma AG, AmbioPharm Inc., Bachem Holding AG, PolyPeptide Group, Sanofi SA, Amylin Pharmaceuticals, CirclePharma, Inc., PeptiDream Inc., Apitope Technology, Arch NioPartners, and Galena Biopharmaceuticals are some of the noteworthy participants in the APAC peptide therapeutics market profiled in this report.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions                                            
    4. Base Currency, Base Year and Forecast Periods                                                     
  2. Research Methodology                                                                    
    1. Analysis Design                                                   
    2. Research Phases                                                 
      1. Secondary Research                                       
      2. Primary Research                              
      3. Data Modelling                                 
      4. Expert Validation                              
    3. Study Timeline                                                    
  3. Report Overview                                                                 
    1. Executive Summary                                           
    2. Key Inferences                                                  
  4. Market Dynamics                                                                
    1. Impact Analysis                                                   
      1. Drivers                                  
      2. Restraints                              
      3. Opportunities                                    
    2. Regulatory Environment                                                  
    3. Technology Timeline & Recent Trends                                                      
  5. Competitor Benchmarking Analysis                                                             
    1. Key Player Benchmarking                                                
      1. Market share analysis                                    
      2. Products/Service                              
      3. Regional Presence                            
    2. Mergers & Acquisition Landscape                                                
    3. Joint Ventures & Collaborations                                                  
  6. Market Segmentation                                                                       
    1. Peptide Therapeutics Market, By Type
      1. Generic
      2. Innovative
      3. Market Size Estimations & Forecasts (2021-2026)                               
      4. Y-o-Y Growth Rate Analysis                                         
      5. Market Attractiveness Index                                       
    2. Peptide Therapeutics Market, By Application                                  
      1. Metabolic
      2. Cardiovascular Disorder
      3. Respiratory
      4. GIT
      5. Anti-infection
      6. Pain
      7. Dermatology
      8. CNS
      9. Renal
      10. Others
      11. Market Size Estimations & Forecasts (2021-2026)                               
      12. Y-o-Y Growth Rate Analysis                                         
      13. Market Attractiveness Index       
    3. Peptide Therapeutics Market, By Type of Manufacturers 
      1. In-house
      2. Outsourced
      3. Market Size Estimations & Forecasts (2021-2026)                               
      4. Y-o-Y Growth Rate Analysis                                         
      5. Market Attractiveness Index       
    4. Peptide Therapeutics Market, By Route of Administration
      1. Parenteral Route
      2. Oral Route
      3. Pulmonary
      4. Mucosal
      5. Others
      6. Market Size Estimations & Forecasts (2021-2026)                               
      7. Y-o-Y Growth Rate Analysis                                         
      8. Market Attractiveness Index       
    5. Peptide Therapeutics Market, By Synthesis Technology
      1. Solid Phase Peptide Synthesis (SPPS)
      2. Liquid Phase Peptide Synthesis (LPPS)
      3. Hybrid Technology
      4. Market Size Estimations & Forecasts (2021-2026)                               
      5. Y-o-Y Growth Rate Analysis                                         
      6. Market Attractiveness Index       
  7. Geographical Landscape                                                                  
    1. Asia Pacific                                             
      1. By Country                                         
        1. China                  
        2. India                    
        3. Japan                  
        4. South Korea
        5. southeast Asia
        6. Australia & NZ
        7. Rest of Asia-Pacific
  8. Key Player Analysis                                                             
    1. Eli Lilly and Company
      1. Business Description                                      
      2. Products/Service                              
      3. Financials                             
      4. SWOT Analysis                                  
      5. Recent Developments                                    
      6. Analyst Overview                              
    2. Amgen, Inc.
    3. Pfizer, Inc.
    4. Bristol-Myers Squibb Company
    5. Ever Neuro Pharma GmbH
    6. Takeda Pharmaceutical Company Limited
    7. AstraZeneca PLC
    8. GlaxoSmithKline plc
    9. Novo Nordisk A/S.
    10. Novartis AG
    11. Zealand Pharma AG
    12. AmbioPharm Inc.
    13. Bachem Holding AG
    14. PolyPeptide Group
    15. Sanofi SA
    16. Amylin Pharmaceuticals
    17. CirclePharma, Inc.
    18. PeptiDream Inc.
    19. Apitope Technology
    20. Arch NioPartners
    21. Galena Biopharmaceuticals
  9. Market Outlook & Investment Opportunities                                                          
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of type, application, type of manufacturers, route of administration and synthesis technology along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Asia Pacific Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Generic Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Innovative Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Metabolic Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Cardiovascular Disorder Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Respiratory Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia Pacific GIT Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific Anti-infection Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia Pacific Pain Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia Pacific Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia Pacific CNS Market, By Region, From 2021 to 2026 (USD Billion)
  13. Asia Pacific Renal Market, By Region, From 2021 to 2026 (USD Billion)
  14. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  15. Asia Pacific Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  16. Asia Pacific In-house Market, By Region, From 2021 to 2026 (USD Billion)
  17. Asia Pacific Outsourced Market, By Region, From 2021 to 2026 (USD Billion)
  18. Asia Pacific Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  19. Asia Pacific Parenteral Route Market, By Region, From 2021 to 2026 (USD Billion)
  20. Asia Pacific Oral Route Market, By Region, From 2021 to 2026 (USD Billion)
  21. Asia Pacific Pulmonary Market, By Region, From 2021 to 2026 (USD Billion)
  22. Asia Pacific Mucosal Market, By Region, From 2021 to 2026 (USD Billion)
  23. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  24. Asia Pacific Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  25. Asia Pacific Solid Phase Peptide Synthesis (SPPS) Market, By Region, From 2021 to 2026 (USD Billion)
  26. Asia Pacific Liquid Phase Peptide Synthesis (LPPS) Market, By Region, From 2021 to 2026 (USD Billion)
  27. Asia Pacific Hybrid Technology Market, By Region, From 2021 to 2026 (USD Billion)
  28. Japan Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  29. Japan Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  30. Japan Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  31. Japan Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  32. Japan Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  33. China Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  34. China Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  35. China Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  36. China Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  37. China Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  38. India Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  39. India Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  40. India Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  41. India Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  42. India Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  43. Australia Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  44. Australia Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  45. Australia Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  46. Australia Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  47. Australia Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  48. South Korea Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  49. South Korea Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  50. South Korea Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  51. South Korea Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  52. South Korea Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample